Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ROCHESTER DRUG COOPERATIVE, INC. v. JOHNSON & JOHNSON et al
Case Number:
2:18-cv-00303
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
December 10, 2018
J&J To Face Bulk Of Buyers' Claims In Remicade Antitrust Suit
A Pennsylvania federal judge largely refused Friday to toss antitrust claims from buyers of Johnson & Johnson immunosuppressant Remicade, concluding that only sham litigation allegations and some state law consumer protection accusations must go while maintaining most of the suit alleging J&J compelled insurers not to cover competing biosimilars.
-
October 26, 2018
J&J Can't Arbitrate Distributor's Claims In Remicade Row
A federal judge in Pennsylvania on Friday rejected Johnson & Johnson's bid to force direct purchasers of the immunosuppressant Remicade to arbitrate claims that it compelled insurers not to cover competing biosimilar versions of the drug, finding that antitrust claims fell outside the scope of their distribution agreement.